Open AccessLooking beyond cancer for cabozantinib-induced cardiotoxicity: evidence of absence or absence of evidence?
Author(s) -
Eugenia Y. Lee,
Andrew T. Yan
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.05.51
Subject(s) - pazopanib , cardiotoxicity , sunitinib , medicine , bevacizumab , axitinib , cabozantinib , oncology , intensive care medicine , cancer , disease , targeted therapy , heart failure , vascular endothelial growth factor , tyrosine kinase inhibitor , tyrosine kinase , vegf receptors , chemotherapy , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom